ENDRA Life Sciences Inc. NDRA
Regular-session close
After hours · Nov 20, 4:00 PM ET
- YTD
- -21.08%
- 1 year
- -36.61%
NDRA free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-5,199,838 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | -5,199,838 | 2,213,505 | Not meaningful |
| FY 2024 | 2024-12-31 | -7,413,343 | 2,160,153 | Not meaningful |
| FY 2023 | 2023-12-31 | -9,573,496 | 3,398,452 | Not meaningful |
| FY 2022 | 2022-12-31 | -12,971,948 | -1,804,564 | Not meaningful |
| FY 2021 | 2021-12-31 | -11,167,384 | -345,456 | Not meaningful |
| FY 2020 | 2020-12-31 | -10,821,928 | -2,189,482 | Not meaningful |
| FY 2019 | 2019-12-31 | -8,632,446 | -829,965 | Not meaningful |
| FY 2018 | 2018-12-31 | -7,802,481 | -4,493,706 | Not meaningful |
| FY 2017 | 2017-12-31 | -3,308,775 | -1,993,152 | Not meaningful |
| FY 2016 | 2016-12-31 | -1,315,623 | -339,085 | Not meaningful |
| FY 2015 | 2015-12-31 | -976,538 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-19T07:00:40.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
